{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:32:24Z","timestamp":1780097544175,"version":"3.54.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013562","name":"Genetics Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000402","name":"Kay Kendall Leukaemia Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/10002071"],"award-info":[{"award-number":["BBS\/E\/D\/10002071"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/RL\/230001B"],"award-info":[{"award-number":["BBS\/E\/RL\/230001B"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/10002071"],"award-info":[{"award-number":["BBS\/E\/D\/10002071"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/RL\/230001B"],"award-info":[{"award-number":["BBS\/E\/RL\/230001B"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/10002071"],"award-info":[{"award-number":["BBS\/E\/D\/10002071"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/10002071"],"award-info":[{"award-number":["BBS\/E\/D\/10002071"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Melville Trust for care and cure cancer"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Acute myeloid leukemia (AML) is the most common type of acute leukemia, accounting for 20% of cases in children and adolescents. Genome-wide studies have identified genes that are commonly mutated in AML, including many epigenetic regulators involved in either DNA methylation (<jats:italic>DNMT3A<\/jats:italic>, <jats:italic>TET2<\/jats:italic>, <jats:italic>IDH1\/2<\/jats:italic>) or histone post-translational modifications (<jats:italic>ASXL1<\/jats:italic>, <jats:italic>EZH2<\/jats:italic>, <jats:italic>MLL1<\/jats:italic>). Several cell lines derived from AML patients are widely used in cancer research. Whether important differences in these cell lines exist remains poorly characterised.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Here, we used RNA sequencing (RNA-Seq) to contrast the transcriptome of four commonly used AML-derived cell lines: THP-1, NOMO-1, MOLM-13 bearing the common initiating t(9;11) translocation, and MV4.11 bearing the t(4;11) translocation. Gene set enrichment analyses and comparison of key transcription and epigenetic regulator genes revealed important differences in the transcriptome, distinguishing these AML models. Among these, we found striking differences in the expression of clusters of genes located on chromosome 19 encoding Zinc Finger (ZNF) transcriptional repressors. Low expression of many ZNF genes within these clusters is associated with poor survival in AML patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present study offers a valuable resource by providing a detailed comparative characterisation of the transcriptome of cell lines within the same AML subtype used as models for leukemia research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12864-025-11415-1","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T02:25:07Z","timestamp":1742955907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transcriptomic characterisation of acute myeloid leukemia cell lines bearing the same t(9;11) driver mutation reveals different molecular signatures"],"prefix":"10.1186","volume":"26","author":[{"given":"Elise","family":"Georges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren Urrutia","family":"Iturritza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lel","family":"Eory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Malysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulduz","family":"Sobhiafshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Archibald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Macqueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Vernimmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"2","key":"11415_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/path.4647","volume":"238","author":"AJ Brazel","year":"2016","unstructured":"Brazel AJ, Vernimmen D. The complexity of epigenetic diseases. J Pathol. 2016;238(2):333\u201344.","journal-title":"J Pathol"},{"issue":"7104","key":"11415_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442(7104):818\u201322.","journal-title":"Nature"},{"issue":"7","key":"11415_CR3","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3324\/haematol.2011.054734","volume":"97","author":"SJ Horton","year":"2012","unstructured":"Horton SJ, Huntly BJ. Recent advances in acute myeloid leukemia stem cell biology. Haematologica. 2012;97(7):966\u201374.","journal-title":"Haematologica"},{"issue":"7488","key":"11415_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, et al. Identification of pre-leukaemic Haematopoietic stem cells in acute leukaemia. Nature. 2014;506(7488):328\u201333.","journal-title":"Nature"},{"issue":"4","key":"11415_CR5","first-page":"328","volume":"11","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel FA, Chavez-Valencia V, Gomez-Guijosa MA, Cortes-Penagos C. Acute myeloid Leukemia-Genetic alterations and their clinical prognosis. Int J Hematol Oncol Stem Cell Res. 2017;11(4):328\u201339.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"2","key":"11415_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.leu.2405078","volume":"22","author":"J Pedersen-Bjergaard","year":"2008","unstructured":"Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia. 2008;22(2):240\u20138.","journal-title":"Leukemia"},{"issue":"4","key":"11415_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48(4):491\u2013507.","journal-title":"Mol Cell"},{"issue":"1","key":"11415_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","volume":"20","author":"SR Daigle","year":"2011","unstructured":"Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J, Johnston LD, Scott MP, Smith JJ, Xiao Y, et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell. 2011;20(1):53\u201365.","journal-title":"Cancer Cell"},{"issue":"1","key":"11415_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327.","journal-title":"Cell"},{"issue":"4","key":"11415_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","volume":"27","author":"D Borkin","year":"2015","unstructured":"Borkin D, He S, Miao H, Kempinska K, Pollock J, Chase J, Purohit T, Malik B, Zhao T, Wang J, et al. Pharmacologic Inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015;27(4):589\u2013602.","journal-title":"Cancer Cell"},{"issue":"4","key":"11415_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm.3832","volume":"21","author":"CW Chen","year":"2015","unstructured":"Chen CW, Koche RP, Sinha AU, Deshpande AJ, Zhu N, Eng R, Doench JG, Xu H, Chu SH, Qi J, et al. DOT1L inhibits SIRT1-mediated epigenetic Silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat Med. 2015;21(4):335\u201343.","journal-title":"Nat Med"},{"issue":"4","key":"11415_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.molcel.2015.10.042","volume":"60","author":"SF Cai","year":"2015","unstructured":"Cai SF, Chen CW, Armstrong SA. Drugging chromatin in cancer: recent advances and novel approaches. Mol Cell. 2015;60(4):561\u201370.","journal-title":"Mol Cell"},{"key":"11415_CR13","doi-asserted-by":"crossref","unstructured":"Skopek R, Palusinska M, Kaczor-Keller K, Pingwara R, Papierniak-Wygladala A, Schenk T, Lewicki S, Zelent A, Szymanski L. Choosing the right cell line for acute myeloid leukemia (AML) research. Int J Mol Sci. 2023; 24(6).","DOI":"10.3390\/ijms24065377"},{"issue":"2","key":"11415_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.leu.2403236","volume":"18","author":"HG Drexler","year":"2004","unstructured":"Drexler HG, Quentmeier H, MacLeod RA. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia. 2004;18(2):227\u201332.","journal-title":"Leukemia"},{"issue":"9","key":"11415_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/sj.leu.2400768","volume":"11","author":"Y Matsuo","year":"1997","unstructured":"Matsuo Y, MacLeod RA, Uphoff CC, Drexler HG, Nishizaki C, Katayama Y, Kimura G, Fujii N, Omoto E, Harada M, et al. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia. 1997;11(9):1469\u201377.","journal-title":"Leukemia"},{"issue":"1","key":"11415_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/blood.V70.1.192.192","volume":"70","author":"B Lange","year":"1987","unstructured":"Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I, Griffin C, Emanuel B, Finan J, Nowell P, et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood. 1987;70(1):192\u20139.","journal-title":"Blood"},{"issue":"2","key":"11415_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C Meyer","year":"2018","unstructured":"Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273\u201384.","journal-title":"Leukemia"},{"issue":"6","key":"11415_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1182\/blood.V60.6.1321.1321","volume":"60","author":"JL Parkin","year":"1982","unstructured":"Parkin JL, Arthur DC, Abramson CS, McKenna RW, Kersey JH, Heideman RL, Brunning RD. Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and Immunologic characteristics. Blood. 1982;60(6):1321\u201331.","journal-title":"Blood"},{"issue":"2","key":"11415_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1182\/blood.V66.2.439.439","volume":"66","author":"RC Stong","year":"1985","unstructured":"Stong RC, Kersey JH. In vitro culture of leukemic cells in t(4;11) acute leukemia. Blood. 1985;66(2):439\u201343.","journal-title":"Blood"},{"issue":"8","key":"11415_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1182\/bloodadvances.2017013748","volume":"2","author":"C Schneidawind","year":"2018","unstructured":"Schneidawind C, Jeong J, Schneidawind D, Kim IS, Duque-Afonso J, Wong SHK, Iwasaki M, Breese EH, Zehnder JL, Porteus M, et al. MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing. Blood Adv. 2018;2(8):832\u201345.","journal-title":"Blood Adv"},{"issue":"1","key":"11415_CR21","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1038\/s41467-021-27270-z","volume":"12","author":"S Rice","year":"2021","unstructured":"Rice S, Jackson T, Crump NT, Fordham N, Elliott N, O\u2019Byrne S, Fanego M, Addy D, Crabb T, Dryden C, et al. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program. Nat Commun. 2021;12(1):6905.","journal-title":"Nat Commun"},{"issue":"2","key":"11415_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.2910260208","volume":"26","author":"S Tsuchiya","year":"1980","unstructured":"Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980;26(2):171\u20136.","journal-title":"Int J Cancer"},{"key":"11415_CR23","unstructured":"Kato Y, Ogura M, Okumura M, Morishima Y, Horita T, Ohno R, Saito H, Hirabayashi N. Establishment of peroxidase positive, human monocytic leukemia cell line (NOMO-1) and its characteristics. Acta Haematol Japan. 1986;49(277)."},{"issue":"7","key":"11415_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u201382.","journal-title":"Nat Biotechnol"},{"issue":"17","key":"11415_CR25","first-page":"3853","volume":"53","author":"JM Hilden","year":"1993","unstructured":"Hilden JM, Chen CS, Moore R, Frestedt J, Kersey JH. Heterogeneity in MLL\/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia. Cancer Res. 1993;53(17):3853\u20136.","journal-title":"Cancer Res"},{"issue":"1","key":"11415_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cancergencyto.2004.01.029","volume":"154","author":"L Montemurro","year":"2004","unstructured":"Montemurro L, Tonelli R, Fazzina R, Martino V, Marino F, Pession A. Identification of two MLL-MLLT3 (alias MLL-AF9) chimeric transcripts in the MOLM-13 cell line. Cancer Genet Cytogenet. 2004;154(1):96\u20137.","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"11415_CR27","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1182\/blood.V84.11.3637.bloodjournal84113637","volume":"84","author":"A Giampaolo","year":"1994","unstructured":"Giampaolo A, Sterpetti P, Bulgarini D, Samoggia P, Pelosi E, Valtieri M, Peschle C. Key functional role and lineage-specific expression of selected HOXB genes in purified hematopoietic progenitor differentiation. Blood. 1994;84(11):3637\u201347.","journal-title":"Blood"},{"issue":"5","key":"11415_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.leu.2401410","volume":"13","author":"H Kawagoe","year":"1999","unstructured":"Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 1999;13(5):687\u201398.","journal-title":"Leukemia"},{"issue":"1","key":"11415_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0301-472X(01)00757-3","volume":"30","author":"N Pineault","year":"2002","unstructured":"Pineault N, Helgason CD, Lawrence HJ, Humphries RK. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol. 2002;30(1):49\u201357.","journal-title":"Exp Hematol"},{"issue":"5","key":"11415_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/leu.2012.356","volume":"27","author":"RA Alharbi","year":"2013","unstructured":"Alharbi RA, Pettengell R, Pandha HS, Morgan R. The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia. 2013;27(5):1000\u20138.","journal-title":"Leukemia"},{"issue":"3","key":"11415_CR31","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/nar\/gkt998","volume":"42","author":"M Rousseau","year":"2014","unstructured":"Rousseau M, Crutchley JL, Miura H, Suderman M, Blanchette M, Dostie J. Hox in motion: tracking HoxA cluster conformation during differentiation. Nucleic Acids Res. 2014;42(3):1524\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11415_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng765","volume":"30","author":"SA Armstrong","year":"2002","unstructured":"Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30(1):41\u20137.","journal-title":"Nat Genet"},{"issue":"6","key":"11415_CR33","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ccell.2018.10.015","volume":"34","author":"B Lu","year":"2018","unstructured":"Lu B, Klingbeil O, Tarumoto Y, Somerville TDD, Huang YH, Wei Y, Wai DC, Low JKK, Milazzo JP, Wu XS, et al. A transcription factor addiction in leukemia imposed by the MLL promoter sequence. Cancer Cell. 2018;34(6):970\u2013e981978.","journal-title":"Cancer Cell"},{"issue":"4","key":"11415_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/MOH.0000000000000245","volume":"23","author":"CT Collins","year":"2016","unstructured":"Collins CT, Hess JL. Deregulation of the HOXA9\/MEIS1 axis in acute leukemia. Curr Opin Hematol. 2016;23(4):354\u201361.","journal-title":"Curr Opin Hematol"},{"issue":"13","key":"11415_CR35","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","volume":"17","author":"E Kroon","year":"1998","unstructured":"Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998;17(13):3714\u201325.","journal-title":"EMBO J"},{"issue":"7","key":"11415_CR36","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/ijc.32967","volume":"147","author":"N Noronha","year":"2020","unstructured":"Noronha N, Ehx G, Meunier MC, Laverdure JP, Theriault C, Perreault C. Major multilevel molecular divergence between THP-1 cells from different biorepositories. Int J Cancer. 2020;147(7):2000\u20136.","journal-title":"Int J Cancer"},{"issue":"3","key":"11415_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/2040620715577614","volume":"6","author":"P Gallipoli","year":"2015","unstructured":"Gallipoli P, Giotopoulos G, Huntly BJ. Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia. Ther Adv Hematol. 2015;6(3):103\u201319.","journal-title":"Ther Adv Hematol"},{"issue":"3","key":"11415_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2015.140822","volume":"101","author":"F Pastore","year":"2016","unstructured":"Pastore F, Levine RL. Epigenetic regulators and their impact on therapy in acute myeloid leukemia. Haematologica. 2016;101(3):269\u201378.","journal-title":"Haematologica"},{"key":"11415_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","volume":"4","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2019;4:62.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"11415_CR40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.advms.2019.07.002","volume":"64","author":"A Mechaal","year":"2019","unstructured":"Mechaal A, Menif S, Abbes S, Safra I. EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients. Adv Med Sci. 2019;64(2):395\u2013401.","journal-title":"Adv Med Sci"},{"issue":"2","key":"11415_CR41","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jcmm.14855","volume":"24","author":"MQ Chu","year":"2020","unstructured":"Chu MQ, Zhang TJ, Xu ZJ, Gu Y, Ma JC, Zhang W, Wen XM, Lin J, Qian J, Zhou JD. EZH2 dysregulation: potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia. J Cell Mol Med. 2020;24(2):1640\u20139.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11415_CR42","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1038\/s41598-021-84708-6","volume":"11","author":"JM Kempf","year":"2021","unstructured":"Kempf JM, Weser S, Bartoschek MD, Metzeler KH, Vick B, Herold T, Volse K, Mattes R, Scholz M, Wange LE, et al. Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML. Sci Rep. 2021;11(1):5838.","journal-title":"Sci Rep"},{"issue":"1","key":"11415_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13148-021-01052-2","volume":"13","author":"J Stomper","year":"2021","unstructured":"Stomper J, Meier R, Ma T, Pfeifer D, Ihorst G, Blagitko-Dorfs N, Greve G, Zimmer D, Platzbecker U, Hagemeijer A, et al. Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML\/MDS patients. Clin Epigenetics. 2021;13(1):77.","journal-title":"Clin Epigenetics"},{"issue":"22","key":"11415_CR44","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Cancer Genome Atlas Research N, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ Jr., Laird PW, et al. Genomic and epigenomic landscapes of adult de Novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059\u201374.","journal-title":"N Engl J Med"},{"issue":"8","key":"11415_CR45","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/leu.2012.56","volume":"26","author":"BG Mar","year":"2012","unstructured":"Mar BG, Bullinger L, Basu E, Schlis K, Silverman LB, Dohner K, Armstrong SA. Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia. Leukemia. 2012;26(8):1881\u20133.","journal-title":"Leukemia"},{"issue":"14","key":"11415_CR46","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1182\/blood-2010-10-311019","volume":"118","author":"AM Jankowska","year":"2011","unstructured":"Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O\u2019Keefe C, et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood. 2011;118(14):3932\u201341.","journal-title":"Blood"},{"issue":"1","key":"11415_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3324\/haematol.2012.064048","volume":"98","author":"SA Kar","year":"2012","unstructured":"Kar SA, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, et al. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica. 2012;98(1):107\u201313.","journal-title":"Haematologica"},{"issue":"6","key":"11415_CR48","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41588-018-0114-z","volume":"50","author":"M Gozdecka","year":"2018","unstructured":"Gozdecka M, Meduri E, Mazan M, Tzelepis K, Dudek M, Knights AJ, Pardo M, Yu L, Choudhary JS, Metzakopian E, et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat Genet. 2018;50(6):883\u201394.","journal-title":"Nat Genet"},{"issue":"23","key":"11415_CR49","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"issue":"22","key":"11415_CR50","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1182\/blood-2015-05-646240","volume":"126","author":"M Garg","year":"2015","unstructured":"Garg M, Nagata Y, Kanojia D, Mayakonda A, Yoshida K, Haridas Keloth S, Zang ZJ, Okuno Y, Shiraishi Y, Chiba K, et al. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood. 2015;126(22):2491\u2013501.","journal-title":"Blood"},{"key":"11415_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1756-0500-2-153","volume":"2","author":"N Adati","year":"2009","unstructured":"Adati N, Huang MC, Suzuki T, Suzuki H, Kojima T. High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line. BMC Res Notes. 2009;2:153.","journal-title":"BMC Res Notes"},{"issue":"5","key":"11415_CR52","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ng.349","volume":"41","author":"G van Haaften","year":"2009","unstructured":"van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O\u2019Meara S, Teague J, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet. 2009;41(5):521\u20133.","journal-title":"Nat Genet"},{"issue":"6","key":"11415_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.exphem.2012.01.017","volume":"40","author":"J Liu","year":"2012","unstructured":"Liu J, Mercher T, Scholl C, Brumme K, Gilliland DG, Zhu N. A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells. Exp Hematol. 2012;40(6):487\u2013e498483.","journal-title":"Exp Hematol"},{"issue":"22","key":"11415_CR54","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1158\/1078-0432.CCR-08-1102","volume":"14","author":"J Greiner","year":"2008","unstructured":"Greiner J, Bullinger L, Guinn BA, Dohner H, Schmitt M. Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells. Clin Cancer Res. 2008;14(22):7161\u20136.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"11415_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/0008-5472.CAN-15-1566","volume":"76","author":"Z Li","year":"2016","unstructured":"Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, et al. PBX3 and MEIS1 cooperate in hematopoietic cells to drive acute myeloid leukemias characterized by a core transcriptome of the MLL-Rearranged disease. Cancer Res. 2016;76(3):619\u201329.","journal-title":"Cancer Res"},{"issue":"10","key":"11415_CR56","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, et al. Heritable GATA2 mutations associated with Familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012\u20137.","journal-title":"Nat Genet"},{"issue":"13","key":"11415_CR57","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1182\/blood.2021011758","volume":"138","author":"CDS Katerndahl","year":"2021","unstructured":"Katerndahl CDS, Rogers ORS, Day RB, Cai MA, Rooney TP, Helton NM, Hoock M, Ramakrishnan SM, Nonavinkere Srivatsan S, Wartman LD, et al. Tumor suppressor function of Gata2 in acute promyelocytic leukemia. Blood. 2021;138(13):1148\u201361.","journal-title":"Blood"},{"issue":"6","key":"11415_CR58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41408-021-00517-0","volume":"11","author":"A Nanaa","year":"2021","unstructured":"Nanaa A, Viswanatha D, Xie Z, Jevremovic D, Nguyen P, Salama ME, Greipp P, Bessonen K, Gangat N, Patnaik M, et al. Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience. Blood Cancer J. 2021;11(6):122.","journal-title":"Blood Cancer J"},{"issue":"6","key":"11415_CR59","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccr.2004.05.023","volume":"5","author":"J O\u2019Neil","year":"2004","unstructured":"O\u2019Neil J, Shank J, Cusson N, Murre C, Kelliher M. TAL1\/SCL induces leukemia by inhibiting the transcriptional activity of E47\/HEB. Cancer Cell. 2004;5(6):587\u201396.","journal-title":"Cancer Cell"},{"issue":"10","key":"11415_CR60","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/leu.2011.140","volume":"25","author":"BA Cardoso","year":"2011","unstructured":"Cardoso BA, de Almeida SF, Laranjeira AB, Carmo-Fonseca M, Yunes JA, Coffer PJ, Barata JT. TAL1\/SCL is downregulated upon histone deacetylase Inhibition in T-cell acute lymphoblastic leukemia cells. Leukemia. 2011;25(10):1578\u201386.","journal-title":"Leukemia"},{"key":"11415_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.exphem.2017.06.001","volume":"53","author":"T Sanda","year":"2017","unstructured":"Sanda T, Leong WZ. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia. Exp Hematol. 2017;53:7\u201315.","journal-title":"Exp Hematol"},{"issue":"1","key":"11415_CR62","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1038\/s41467-021-24044-5","volume":"12","author":"L Yang","year":"2021","unstructured":"Yang L, Chen F, Zhu H, Chen Y, Dong B, Shi M, Wang W, Jiang Q, Zhang L, Huang X, et al. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia. Nat Commun. 2021;12(1):3708.","journal-title":"Nat Commun"},{"issue":"18","key":"11415_CR63","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1182\/blood-2017-10-810622","volume":"131","author":"JC Peeken","year":"2018","unstructured":"Peeken JC, Jutzi JS, Wehrle J, Koellerer C, Staehle HF, Becker H, Schoenwandt E, Seeger TS, Schanne DH, Gothwal M, et al. Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. Blood. 2018;131(18):2065\u201373.","journal-title":"Blood"},{"issue":"16","key":"11415_CR64","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1182\/blood-2018-09-875047","volume":"133","author":"JS Jutzi","year":"2019","unstructured":"Jutzi JS, Basu T, Pellmann M, Kaiser S, Steinemann D, Sanders MA, Hinai ASA, Zeilemaker A, Bojtine Kovacs S, Koellerer C, et al. Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood. 2019;133(16):1766\u201377.","journal-title":"Blood"},{"issue":"21","key":"11415_CR65","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1182\/blood.2020010402","volume":"138","author":"C Marcault","year":"2021","unstructured":"Marcault C, Zhao LP, Maslah N, Verger E, Daltro de Oliveira R, Soret-Dulphy J, Cazaux M, Gauthier N, Roux B, Clappier E, et al. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 2021;138(21):2142\u20138.","journal-title":"Blood"},{"key":"11415_CR66","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/ncomms10498","volume":"7","author":"W Lehmann","year":"2016","unstructured":"Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, Brabletz S, Stemmler MP, Brabletz T. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498.","journal-title":"Nat Commun"},{"issue":"5","key":"11415_CR67","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.it.2019.03.001","volume":"40","author":"CL Scott","year":"2019","unstructured":"Scott CL, Omilusik KD. ZEBs: novel players in immune cell development and function. Trends Immunol. 2019;40(5):431\u201346.","journal-title":"Trends Immunol"},{"key":"11415_CR68","doi-asserted-by":"crossref","unstructured":"Almotiri A, Alzahrani H, Menendez-Gonzalez JB, Abdelfattah A, Alotaibi B, Saleh L, Greene A, Georgiou M, Gibbs A, Alsayari A et al. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia. J Clin Invest. 2021;131(1).","DOI":"10.1172\/JCI129115"},{"key":"11415_CR69","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1038\/ncomms6794","volume":"6","author":"S Goossens","year":"2015","unstructured":"Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, Taghon T, Tremblay CS, Costa M, Farhang Ghahremani M, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794.","journal-title":"Nat Commun"},{"issue":"8","key":"11415_CR70","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3324\/haematol.2018.207837","volume":"104","author":"S Goossens","year":"2019","unstructured":"Goossens S, Wang J, Tremblay CS, De Medts J, T\u2019Sas S, Nguyen T, Saw J, Haigh K, Curtis DJ, Van Vlierberghe P, et al. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms. Haematologica. 2019;104(8):1608\u201316.","journal-title":"Haematologica"},{"issue":"10","key":"11415_CR71","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/emboj\/cdg225","volume":"22","author":"AA Postigo","year":"2003","unstructured":"Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFbeta\/BMP signaling pathway. EMBO J. 2003;22(10):2443\u201352.","journal-title":"EMBO J"},{"issue":"1","key":"11415_CR72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1182\/blood-2002-02-0398","volume":"101","author":"B Liu","year":"2003","unstructured":"Liu B, Sun Y, Jiang F, Zhang S, Wu Y, Lan Y, Yang X, Mao N. Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesis. Blood. 2003;101(1):124\u201333.","journal-title":"Blood"},{"key":"11415_CR73","doi-asserted-by":"publisher","first-page":"554948","DOI":"10.3389\/fgene.2021.554948","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Clay-Gilmour AI, Karaesmen E, Rizvi A, Zhu Q, Yan L, Preus L, Liu S, Wang Y, Griffiths E, et al. Genome-Wide association analyses identify variants in IRF4 associated with acute myeloid leukemia and myelodysplastic syndrome susceptibility. Front Genet. 2021;12:554948.","journal-title":"Front Genet"},{"issue":"2","key":"11415_CR74","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.leu.2404895","volume":"22","author":"D Heintel","year":"2008","unstructured":"Heintel D, Zojer N, Schreder M, Strasser-Weippl K, Kainz B, Vesely M, Gisslinger H, Drach J, Gaiger A, Jager U, et al. Expression of MUM1\/IRF4 mRNA as a prognostic marker in patients with multiple myeloma. Leukemia. 2008;22(2):441\u20135.","journal-title":"Leukemia"},{"issue":"7","key":"11415_CR75","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tcb.2007.07.004","volume":"17","author":"C Nerlov","year":"2007","unstructured":"Nerlov C. The C\/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007;17(7):318\u201324.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"11415_CR76","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2002-05-1374","volume":"101","author":"BT Truong","year":"2003","unstructured":"Truong BT, Lee YJ, Lodie TA, Park DJ, Perrotti D, Watanabe N, Koeffler HP, Nakajima H, Tenen DG, Kogan SC. CCAAT\/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood. 2003;101(3):1141\u20138.","journal-title":"Blood"},{"issue":"5","key":"11415_CR77","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1532\/IJH97.05051","volume":"81","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Rosenbauer F, Steidl U, Owens BM, Tenen DG. Role of transcription factors C\/EBPalpha and PU.1 in normal hematopoiesis and leukemia. Int J Hematol. 2005;81(5):368\u201377.","journal-title":"Int J Hematol"},{"issue":"8","key":"11415_CR78","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","volume":"109","author":"T Akasaka","year":"2007","unstructured":"Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, Karran EL, Brown DG, Cain K, Harder L, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2007;109(8):3451\u201361.","journal-title":"Blood"},{"issue":"53","key":"11415_CR79","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1038\/onc.2008.285","volume":"27","author":"H Matsushita","year":"2008","unstructured":"Matsushita H, Nakajima H, Nakamura Y, Tsukamoto H, Tanaka Y, Jin G, Yabe M, Asai S, Ono R, Nosaka T, et al. C\/EBPalpha and C\/EBPvarepsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene. Oncogene. 2008;27(53):6749\u201360.","journal-title":"Oncogene"},{"issue":"5","key":"11415_CR80","first-page":"2121","volume":"44","author":"J Wang","year":"2020","unstructured":"Wang J, Xiong Y. HSH2D contributes to methotrexate resistance in human Tcell acute lymphoblastic leukaemia. Oncol Rep. 2020;44(5):2121\u20139.","journal-title":"Oncol Rep"},{"issue":"2","key":"11415_CR81","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-0609.2005.00473.x","volume":"75","author":"J Ekberg","year":"2005","unstructured":"Ekberg J, Holm C, Jalili S, Richter J, Anagnostaki L, Landberg G, Persson JL. Expression of Cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome. Eur J Haematol. 2005;75(2):106\u201315.","journal-title":"Eur J Haematol"},{"issue":"23","key":"11415_CR82","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1182\/blood-2011-07-365890","volume":"119","author":"S Ochsenreither","year":"2012","unstructured":"Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M, Warren EH, et al. Cyclin-A1 represents a new Immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood. 2012;119(23):5492\u2013501.","journal-title":"Blood"},{"issue":"5","key":"11415_CR83","first-page":"913","volume":"57","author":"R Yang","year":"1997","unstructured":"Yang R, Morosetti R, Koeffler HP. Characterization of a second human Cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res. 1997;57(5):913\u201320.","journal-title":"Cancer Res"},{"issue":"1","key":"11415_CR84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/gcc.20500","volume":"47","author":"DL Stirewalt","year":"2008","unstructured":"Stirewalt DL, Meshinchi S, Kopecky KJ, Fan W, Pogosova-Agadjanyan EL, Engel JH, Cronk MR, Dorcy KS, McQuary AR, Hockenbery D, et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer. 2008;47(1):8\u201320.","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"11415_CR85","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1073\/pnas.121540098","volume":"98","author":"C Liao","year":"2001","unstructured":"Liao C, Wang XY, Wei HQ, Li SQ, Merghoub T, Pandolfi PP, Wolgemuth DJ. Altered myelopoiesis and the development of acute myeloid leukemia in Transgenic mice overexpressing Cyclin A1. Proc Natl Acad Sci U S A. 2001;98(12):6853\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"11415_CR86","first-page":"129","volume":"34","author":"U Krug","year":"2009","unstructured":"Krug U, Yasmeen A, Beger C, Baumer N, Dugas M, Berdel WE, Muller-Tidow C. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells. Int J Oncol. 2009;34(1):129\u201336.","journal-title":"Int J Oncol"},{"issue":"7","key":"11415_CR87","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3324\/haematol.2016.163022","volume":"102","author":"G Daniele","year":"2017","unstructured":"Daniele G, Simonetti G, Fusilli C, Iacobucci I, Lonoce A, Palazzo A, Lomiento M, Mammoli F, Marsano RM, Marasco E, et al. Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells. Haematologica. 2017;102(7):1204\u201314.","journal-title":"Haematologica"},{"issue":"17","key":"11415_CR88","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/onc.2015.289","volume":"35","author":"HJ Li","year":"2016","unstructured":"Li HJ, Yu PN, Huang KY, Su HY, Hsiao TH, Chang CP, Yu MH, Lin YW. NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transition. Oncogene. 2016;35(17):2266\u201378.","journal-title":"Oncogene"},{"issue":"6","key":"11415_CR89","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-06-3993","volume":"67","author":"KH Taylor","year":"2007","unstructured":"Taylor KH, Pena-Hernandez KE, Davis JW, Arthur GL, Duff DJ, Shi H, Rahmatpanah FB, Sjahputera O, Caldwell CW. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res. 2007;67(6):2617\u201325.","journal-title":"Cancer Res"},{"issue":"4","key":"11415_CR90","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1073\/pnas.85.4.1232","volume":"85","author":"S Murao","year":"1988","unstructured":"Murao S, Stevens FJ, Ito A, Huberman E. Myeloperoxidase: a myeloid cell nuclear antigen with DNA-binding properties. Proc Natl Acad Sci U S A. 1988;85(4):1232\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"11415_CR91","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med. 1985;103(4):620\u20135.","journal-title":"Ann Intern Med"},{"issue":"2","key":"11415_CR92","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/ijlh.13988","volume":"45","author":"OK Weinberg","year":"2023","unstructured":"Weinberg OK, Dennis J, Zia H, Chen P, Chu A, Koduru P, Luu HS, Fuda F, Chen W. Adult mixed phenotype acute leukemia (MPAL): b\/myeloid MPAL(isoMPO) is distinct from other MPAL subtypes. Int J Lab Hematol. 2023;45(2):170\u20138.","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"11415_CR93","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jha2.855","volume":"5","author":"WJ Wang","year":"2024","unstructured":"Wang WJ, Gehris BT, Rivera D, Ak S, Feng D, Wang W, Hu Z. Bone marrow-restricted aberrant myeloperoxidase expression in B-acute lymphoblastic leukemia: A diagnostic dilemma and mimicry of mixed phenotype acute leukemia. EJHaem. 2024;5(2):403\u20137.","journal-title":"EJHaem"},{"issue":"3","key":"11415_CR94","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccell.2015.07.017","volume":"28","author":"TD Somerville","year":"2015","unstructured":"Somerville TD, Wiseman DH, Spencer GJ, Huang X, Lynch JT, Leong HS, Williams EL, Cheesman E, Somervaille TC. Frequent derepression of the mesenchymal transcription factor gene FOXC1 in acute myeloid leukemia. Cancer Cell. 2015;28(3):329\u201342.","journal-title":"Cancer Cell"},{"issue":"12","key":"11415_CR95","doi-asserted-by":"publisher","first-page":"109725","DOI":"10.1016\/j.celrep.2021.109725","volume":"36","author":"F Simeoni","year":"2021","unstructured":"Simeoni F, Romero-Camarero I, Camera F, Amaral FMR, Sinclair OJ, Papachristou EK, Spencer GJ, Lie ALM, Lacaud G, Wiseman DH, et al. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. Cell Rep. 2021;36(12):109725.","journal-title":"Cell Rep"},{"issue":"5","key":"11415_CR96","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41419-022-04873-y","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ma X, Huang J, Yang X, Kang M, Sun X, Li H, Wu Y, Zhang H, Zhu Y, et al. Somatic FOXC1 insertion mutation remodels the immune microenvironment and promotes the progression of childhood acute lymphoblastic leukemia. Cell Death Dis. 2022;13(5):431.","journal-title":"Cell Death Dis"},{"issue":"6","key":"11415_CR97","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1182\/blood-2011-06-359406","volume":"119","author":"G Bungartz","year":"2012","unstructured":"Bungartz G, Land H, Scadden DT, Emerson SG. NF-Y is necessary for hematopoietic stem cell proliferation and survival. Blood. 2012;119(6):1380\u20139.","journal-title":"Blood"},{"issue":"11","key":"11415_CR98","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.stemcr.2021.10.001","volume":"16","author":"H Lawson","year":"2021","unstructured":"Lawson H, van de Lagemaat LN, Barile M, Tavosanis A, Durko J, Villacreces A, Bellani A, Mapperley C, Georges E, Martins-Costa C, et al. CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation. Stem Cell Rep. 2021;16(11):2784\u201397.","journal-title":"Stem Cell Rep"},{"issue":"7","key":"11415_CR99","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood-2004-09-3630","volume":"105","author":"SF Landrette","year":"2005","unstructured":"Landrette SF, Kuo YH, Hensen K, van Barjesteh S, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in Cooperation with Cbfb-MYH11. Blood. 2005;105(7):2900\u20137.","journal-title":"Blood"},{"issue":"D1","key":"11415_CR100","doi-asserted-by":"publisher","first-page":"D923","DOI":"10.1093\/nar\/gky872","volume":"47","author":"D van der Meer","year":"2019","unstructured":"van der Meer D, Barthorpe S, Yang W, Lightfoot H, Hall C, Gilbert J, Francies HE, Garnett MJ. Cell model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models. Nucleic Acids Res. 2019;47(D1):D923\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"11415_CR101","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1182\/blood.V79.9.2378.2378","volume":"79","author":"K Sugimoto","year":"1992","unstructured":"Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F, Takaku F, Yazaki Y, Hirai H. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood. 1992;79(9):2378\u201383.","journal-title":"Blood"},{"issue":"11","key":"11415_CR102","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1016\/j.celrep.2019.08.061","volume":"28","author":"LA Donehower","year":"2019","unstructured":"Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, Li X, Babur O, Hsu TK, Lichtarge O, et al. Integrated analysis of TP53 gene and pathway alterations in the Cancer genome atlas. Cell Rep. 2019;28(11):3010.","journal-title":"Cell Rep"},{"issue":"5","key":"11415_CR103","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1101\/gr.4842106","volume":"16","author":"S Huntley","year":"2006","unstructured":"Huntley S, Baggott DM, Hamilton AT, Tran-Gyamfi M, Yang S, Kim J, Gordon L, Branscomb E, Stubbs L. A comprehensive catalog of human KRAB-associated zinc finger genes: insights into the evolutionary history of a large family of transcriptional repressors. Genome Res. 2006;16(5):669\u201377.","journal-title":"Genome Res"},{"issue":"19","key":"11415_CR104","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1016\/j.molcel.2024.08.037","volume":"84","author":"S Nabeel-Shah","year":"2024","unstructured":"Nabeel-Shah S, Pu S, Burns JD, Braunschweig U, Ahmed N, Burke GL, Lee H, Radovani E, Zhong G, Tang H, et al. C2H2-zinc-finger transcription factors bind RNA and function in diverse post-transcriptional regulatory processes. Mol Cell. 2024;84(19):3810\u2013e38253810.","journal-title":"Mol Cell"},{"issue":"3","key":"11415_CR105","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cdd.2013.150","volume":"21","author":"S Lukic","year":"2014","unstructured":"Lukic S, Nicolas JC, Levine AJ. The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses. Cell Death Differ. 2014;21(3):381\u20137.","journal-title":"Cell Death Differ"},{"issue":"6","key":"11415_CR106","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1158\/0008-5472.CAN-23-1237","volume":"84","author":"F Martins","year":"2024","unstructured":"Martins F, Rosspopoff O, Carlevaro-Fita J, Forey R, Offner S, Planet E, Pulver C, Pak H, Huber F, Michaux J, et al. A cluster of evolutionarily recent KRAB zinc finger proteins protects Cancer cells from replicative Stress-Induced inflammation. Cancer Res. 2024;84(6):808\u201326.","journal-title":"Cancer Res"},{"issue":"3","key":"11415_CR107","doi-asserted-by":"publisher","first-page":"305","DOI":"10.21873\/cgp.20322","volume":"19","author":"SO Heyliger","year":"2022","unstructured":"Heyliger SO, Soliman KFA, Saulsbury MD, Reams RR. Prognostic relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc finger proteins in clear cell renal carcinoma. Cancer Genomics Proteom. 2022;19(3):305\u201327.","journal-title":"Cancer Genomics Proteom"},{"issue":"4","key":"11415_CR108","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/gb-2009-10-4-r40","volume":"10","author":"H Kawaji","year":"2009","unstructured":"Kawaji H, Severin J, Lizio M, Waterhouse A, Katayama S, Irvine KM, Hume DA, Forrest AR, Suzuki H, Carninci P, et al. The FANTOM web resource: from mammalian transcriptional landscape to its dynamic regulation. Genome Biol. 2009;10(4):R40.","journal-title":"Genome Biol"},{"issue":"1","key":"11415_CR109","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"7","key":"11415_CR110","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"12","key":"11415_CR111","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"11415_CR112","unstructured":"Team RC. R: A language and environment for statistical computing. Vienna, Austria 2013."},{"key":"11415_CR113","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/1471-2164-9-488","volume":"9","author":"T Hulsen","year":"2008","unstructured":"Hulsen T, de Vlieg J, Alkema W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008;9:488.","journal-title":"BMC Genomics"},{"issue":"1","key":"11415_CR114","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pro.4218","volume":"31","author":"PD Thomas","year":"2022","unstructured":"Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, Mi H. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31(1):8\u201322.","journal-title":"Protein Sci"},{"key":"11415_CR115","unstructured":"Gene Ontology C, Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, Feuermann M, Gaudet P, Harris NL et al. The gene ontology knowledgebase in 2023. Genetics. 2023;224(1)."},{"issue":"W1","key":"11415_CR116","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, Wishart DS. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 2016;44(W1):W147\u2013153.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"11415_CR117","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"11415_CR118","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1093\/nar\/gky401","volume":"46","author":"H Liu","year":"2018","unstructured":"Liu H, Lorenzini PA, Zhang F, Xu S, Wong MSM, Zheng J, Roca X. Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator. Nucleic Acids Res. 2018;46(12):6069\u201386.","journal-title":"Nucleic Acids Res"},{"key":"11415_CR119","doi-asserted-by":"crossref","unstructured":"Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y, Hou I, Zhong Q, Zheng Z, Xiao H et al. RNA sequencing analyses of gene expression during Epstein-Barr virus infection of primary B lymphocytes. J Virol. 2019; 93(13).","DOI":"10.1128\/JVI.00226-19"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-11415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-025-11415-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-025-11415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T23:09:10Z","timestamp":1743289750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-025-11415-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11415"],"URL":"https:\/\/doi.org\/10.1186\/s12864-025-11415-1","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"300"}}